MicroTech Medical Hong Kong IPO Greeted with Yawns

Diabetes device maker’s shares go largely unchanged in first four trading days despite attracting Invesco and two other mid-sized U.S. fund managers Key Takeaways: Diabetes device maker MicroTech Medical’s shares have gone largely unchanged in their first four trading days after the company raised $250 million in its Hong Kong IPO Despite attracting U.S. giant Invesco, company is vying for investor attention with a growing field of newly listed China-focused medical device makers By Doug Young Another day, another medical IPO. That’s been a major theme for 2021 in Hong…

Read More